Ishikawa-Ichikawa, A.; Islas-MartÃnez, J.A.; Rios-Garcia, E.; Tejado-Gallegos, L.F.; RamÃrez-MarÃn, P.M.
Real-World Safety of Acalabrutinib in Mexico: A Postmarketing Surveillance Study. Pharmacoepidemiology 2026, 5, 7.
https://doi.org/10.3390/pharma5010007
AMA Style
Ishikawa-Ichikawa A, Islas-MartÃnez JA, Rios-Garcia E, Tejado-Gallegos LF, RamÃrez-MarÃn PM.
Real-World Safety of Acalabrutinib in Mexico: A Postmarketing Surveillance Study. Pharmacoepidemiology. 2026; 5(1):7.
https://doi.org/10.3390/pharma5010007
Chicago/Turabian Style
Ishikawa-Ichikawa, Akemi, Jorge Alberto Islas-MartÃnez, Eduardo Rios-Garcia, Luis Fernando Tejado-Gallegos, and Pamela Monserrat RamÃrez-MarÃn.
2026. "Real-World Safety of Acalabrutinib in Mexico: A Postmarketing Surveillance Study" Pharmacoepidemiology 5, no. 1: 7.
https://doi.org/10.3390/pharma5010007
APA Style
Ishikawa-Ichikawa, A., Islas-MartÃnez, J. A., Rios-Garcia, E., Tejado-Gallegos, L. F., & RamÃrez-MarÃn, P. M.
(2026). Real-World Safety of Acalabrutinib in Mexico: A Postmarketing Surveillance Study. Pharmacoepidemiology, 5(1), 7.
https://doi.org/10.3390/pharma5010007